| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | trifluoperazine | CTRPv2 | pan-cancer | AAC | 0.22 | 2e-09 |
| mRNA | AGK-2 | CTRPv2 | pan-cancer | AAC | 0.19 | 4e-07 |
| mRNA | ruxolitinib | CTRPv2 | pan-cancer | AAC | 0.14 | 1e-05 |
| mRNA | fulvestrant | CTRPv2 | pan-cancer | AAC | 0.28 | 0.0001 |
| mRNA | CHEMBL374350 | CTRPv2 | pan-cancer | AAC | 0.14 | 0.0001 |
| mRNA | BRD-K55473186 | CTRPv2 | pan-cancer | AAC | 0.17 | 0.0002 |
| mRNA | foretinib | GDSC1000 | pan-cancer | AAC | -0.12 | 0.0002 |
| mRNA | ruxolitinib | GDSC1000 | pan-cancer | AAC | 0.12 | 0.0002 |
| mRNA | prochlorperazine | CTRPv2 | pan-cancer | AAC | 0.12 | 0.0005 |
| mRNA | thapsigargin | GDSC1000 | pan-cancer | AAC | -0.12 | 0.0006 |